Literature DB >> 15007705

Use of intravenous polymyxin B during continuous venovenous hemodialysis.

J C Sarria1, F Angulo-Pernett, R C Kimbrough, C S McVay, A M Vidal.   

Abstract

Described here is the case of a 23-year-old male with Acinetobacter baumannii sepsis and acute renal failure requiring continuous venovenous hemodialysis treated successfully with intravenous polymyxin B. The drug was administered as a loading dose of 2.5 mg/kg, followed by 2 doses of 1 mg/kg on days 4 and 8, then 0.8 mg/kg daily to complete a 24-day course. A discussion of dosing recommendations for polymyxins in dialysis is presented.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007705     DOI: 10.1007/s10096-004-1106-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

Review 1.  Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.

Authors:  M E Evans; D J Feola; R P Rapp
Journal:  Ann Pharmacother       Date:  1999-09       Impact factor: 3.154

2.  SERUM CONCENTRATIONS OF COLISTIN IN PATIENTS WITH NORMAL AND IMPAIRED RENAL FUNCTION.

Authors:  D N MACKAY; D KAYE
Journal:  N Engl J Med       Date:  1964-02-20       Impact factor: 91.245

3.  Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.

Authors:  A S Levin; A A Barone; J Penço; M V Santos; I S Marinho; E A Arruda; E I Manrique; S F Costa
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

Review 4.  The polymyxins.

Authors:  P D Hoeprich
Journal:  Med Clin North Am       Date:  1970-09       Impact factor: 5.456

5.  Colistin toxicity. Neuromuscular and renal manifestations. Two cases treated by hemodialysis.

Authors:  D A Duncan
Journal:  Minn Med       Date:  1973-01

6.  Colistin sulphomethate sodium administration in the presence of severe renal failure and during haemodialysis and peritoneal dialysis.

Authors:  J R Curitis; J B Eastwood
Journal:  Br Med J       Date:  1968-02-24

7.  The effects of renal impairment, peritoneal dialysis, and hemodialysis on serum sodium colistimethate levels.

Authors:  N J Goodwin; E A Friedman
Journal:  Ann Intern Med       Date:  1968-05       Impact factor: 25.391

8.  Peritoneal dialysis in colistin intoxication: report of a case.

Authors:  H M Swick; E Maxwell; P Charache; S Levin
Journal:  J Pediatr       Date:  1969-06       Impact factor: 4.406

9.  Removal and absorption of antibiotics in patients with renal failure undergoing peritoneal dialysis. Tetracycline, chloramphenicol, kanamycin, and colistimethate.

Authors:  P A Greenberg; J P Sanford
Journal:  Ann Intern Med       Date:  1967-03       Impact factor: 25.391

10.  Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients.

Authors:  Nikolaos Markou; Haralampos Apostolakos; Christiana Koumoudiou; Maria Athanasiou; Alexandra Koutsoukou; Ioannis Alamanos; Leonidas Gregorakos
Journal:  Crit Care       Date:  2003-07-28       Impact factor: 9.097

View more
  4 in total

Review 1.  Polymyxins revisited.

Authors:  David Landman; Claudiu Georgescu; Don Antonio Martin; John Quale
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 2.  Treatment options for multidrug-resistant Acinetobacter species.

Authors:  Jacob Gilad; Yehuda Carmeli
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Polymicrobial Ventilator-Associated Pneumonia: Fighting In Vitro Candida albicans-Pseudomonas aeruginosa Biofilms with Antifungal-Antibacterial Combination Therapy.

Authors:  Maria E Rodrigues; Susana P Lopes; Cláudia R Pereira; Nuno F Azevedo; Anália Lourenço; Mariana Henriques; Maria O Pereira
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

4.  Convulsions in a critically ill patient on hemodialysis: Possible role of low dose colistin.

Authors:  Kanwalpreet Sodhi; Rahul Kohli; Basjinder Kaur; Sidhartha Garg; Anupam Shrivastava; Manender Kumar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.